States struggle with peptide regs. No matter what decision FDA makes when it comes to adding peptides to the 503A Bulks List, it could easily be more than a year before we see any real changes. Until then — and possibly after — states are, to quote the Washington Post article, “scrambling to protect consumers” from illicit peptides … that’s if they even have the authority or resources to do that.
Trouble with Georgia’s med spas. We are shocked, shocked, to read that, when the Georgia Composite Medical Board conducted surprise inspections of med spas and IV clinics (and their ilk), it found a dangerous mess: “...medical services being provided by unlicensed workers, medications being unlawfully compounded, [and] healthcare workers practicing outside of their scope of training.” Oh, and sometimes without even physician oversight or medical exams.
Both these stories ↑ are solid arguments for our top policy proposal: med spa regulation. (See “The deets on those real solutions.”) Patients shouldn’t be rolling the dice when it comes to the drugs they put in their bodies.